| We can evaluate percutaneous absorption of pharmaceuticals and cosmetics by our unique in vitro-in silico technology |
Simulation software for transdermal drug delivery
SKIN-CAD®
~ Prediction of blood concentration from in vitro skin permeation data ~
SKIN-CAD users:
pharmaceutical companies and universities
in Japan, EU and US
Clients:
many pharmaceutical, cosmetic and chemical companies
in Japan
Skin permeation study / Release study
~ We can design and implement optimal in vitro studies to clients ~
Contact us: info@biocom.co.jp or Inquiry Form
| About us | Company name: President: Established: Address: | Biocom Systems, Inc. Daisuke Mori, Ph.D. 2001-08-10 1-1 Hyakunen-koen, Kurume city, Fukuoka 839-0864, JAPAN |
| Partnership | Research: SKIN-CAD agent: | Hikima Lab. at Kyushu Institute of Technology (Iizuka, Fukuoka) FQS Poland Sp.z.o.o. (subsidiary of Fujitsu) |
| SKIN-CAD® | SKIN-CAD® is software for skin-body pharmacokinetic simulation developed based on percutaneous absorption model. SKIN-CAD® can predict skin permeation amount and blood concentration by input of various model parameters. It can also analyze the effects of metabolism and binding in the skin, the enhancement by iontophoretic application, and the pharmacokinetic- pharmacodynamic model, etc. |
